Professional Degree courses in Dentistry, Education, Law, Medicine and Theology (MTS, MDiv)
Courses offered by Continuing Studies
Graduate Studies courses
* These courses are equivalent to pre-university introductory courses and may be counted for credit in the student's record, unless these courses were taken in a preliminary year. They may not be counted toward essay or breadth requirements, or used to meet modular admission requirements unless it is explicitly stated in the Senate-approved outline of the module.
1.0 course not designated as an essay course
0.5 course offered in first term
0.5 course offered in second term
0.5 course offered in first and/or second term
1.0 essay course
0.5 essay course offered in first term
0.5 essay course offered in second term
0.5 essay course offered in first and/or second term
1.0 accelerated course (8 weeks)
1.0 accelerated course (6 weeks)
0.5 graduate course offered in summer term (May - August)
0.25 course offered within a regular session
0.25 course offered in other than a regular session
1.0 accelerated course (full course offered in one term)
0.5 course offered in other than a regular session
0.5 essay course offered in other than a regular session
A course that must be successfully completed prior to registration for credit in the desired course.
A course that must be taken concurrently with (or prior to registration in) the desired course.
Courses that overlap sufficiently in course content that both cannot be taken for credit.
Many courses at Western have a significant writing component. To recognize student achievement, a number of such courses have been designated as essay courses and will be identified on the student's record (E essay full course; F/G/Z essay half-course).
A first year course that is listed by a department offering a module as a requirement for admission to the module. For admission to an Honors Specialization module or Double Major modules in an Honors Bachelor degree, at least 3.0 courses will be considered principal courses.
A course for students in the BSc in Nursing and other Health Sciences programs as well as students in BMSc and BSc programs, to provide a basic understanding of the fundamentals of drug action and the mechanisms of action and therapeutic use of the important classes of drugs.
A systems-based pharmacology course surveying the range of drugs used to treat disease processes affecting various organs of the body (e.g. cardiovascular disease, neurological diseases, etc.) with emphasis on drug targets, mechanisms of drug action, and adverse effects.
This course will cover gastrointestinal secretion, motility, digestion, absorption, hepatic and pancreatic physiology. Specific areas will include: gut-brain-liver axis and nutrient metabolism, exocrine and endocrine pancreas, liver and lipid metabolism. Relevant pathologies and disease states, including obesity, diabetes, and metabolic syndrome along with current therapeutic strategies will be covered.
This course explores how drugs and endogenous compounds mediate their biological effects through nuclear signalling pathways. The emphasis will be on aspects of gene regulation and signalling by nuclear hormone receptors - a family of ligand dependent transcription factors essential for normal metabolism, development and reproduction.
Prerequisite(s):Biochemistry 2280A and registration in Year 4, or permission of the Department.
Clinical pharmacology is a scientific and medical discipline dedicated to the bench-to-bedside study of drug action through an in-depth knowledge of human pharmacology and therapeutics. This course in clinical pharmacology focuses on fundamental concepts highlighted with examples from clinical cases, therapeutic applications and relevance to drug discovery and development.
This course is designed to give students a basic understanding of the molecular pharmacology and therapeutic properties of anticancer agents. The focus is on molecular mechanisms of cancer chemotherapy, and will include drug resistance and the roles of receptor kinases and G protein-coupled receptors in existing and novel cancer therapies.
This course will cover the pharmacological and pathophysiological effects of non-medicinal drug use including mechanisms of action, tolerance and addiction, long-term effects, side effects and toxicity, treatment of addictions and overdoses. Pharmacokinetics will also be examined including routes of administration, activation, deactivation, elimination, and drug-drug interactions.
This course will focus on the cellular and molecular mechanisms underlying the actions of drugs on the central and peripheral nervous systems. The focus will be on recent developments in the field of neuroscience and their impact on our understanding of the actions, and development of, new drugs.
Contemporary use of medicines derived from natural sources. Regulatory aspects of their use and the scientific basis for assessment of efficacy, quality, and safety of these products will be discussed. The mechanism(s) of beneficial and harmful effects of selected natural health products, including herb-drug interactions, will be included.
An examination of how mechanisms that regulate cell proliferation affect normal tissue repair and cause abnormalities, such as tumour formation and poor regeneration after injury. The course explores the basic molecular and cellular processes of relevant human disorders and the clinically useful pharmacological and regenerative medical therapies.
This course will present mechanisms of major receptor, ion channel, exchanger and other protein actions that drive cell signalling processes in health and disease. Pharmacological interventions and drug design will be discussed in relation to dysfunctional cell signalling pathways and available protein structure information.
A course dealing with the pharmacological and toxicological principles underlying the adverse effects of xenobiotics in humans. In addition to reviewing mechanisms of toxicity in humans, the course will include overviews of the principles of management of human poisoning, the principles of chronic toxicity and of drug safety in humans.